Literature DB >> 14711079

Antimicrobial tissue concentrations.

Ping Liu1, Hartmut Derendorf.   

Abstract

The clinical outcome of anti-infective treatment is determined by both PK and PD properties of the antibiotic. Only the free tissue concentrations of antibiotics at the target site, which are usually lower than the total plasma concentrations, are responsible for therapeutic effect. The free antibiotic concentrations at the site of action are a more appropriate PK input value for PK-PD analysis. The unbound tissue concentrations can be measured directly by microdialysis. Using plasma concentrations overestimates the target site concentrations and its clinical efficacy. The optimal dosing regimens of antibiotics have an impact on patients' outcome and cost of therapy, and reduce the emergence of resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711079     DOI: 10.1016/s0891-5520(03)00060-6

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  15 in total

1.  Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining Fluid.

Authors:  Pyry A J Välitalo; Koen Griffioen; Matthew L Rizk; Sandra A G Visser; Meindert Danhof; Gaori Rao; Piet H van der Graaf; J G Coen van Hasselt
Journal:  Pharm Res       Date:  2015-12-01       Impact factor: 4.200

2.  Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid.

Authors:  J G Coen van Hasselt; Matthew L Rizk; Mallika Lala; Cynthia Chavez-Eng; Sandra A G Visser; Thomas Kerbusch; Meindert Danhof; Gauri Rao; Piet H van der Graaf
Journal:  Br J Clin Pharmacol       Date:  2016-04-01       Impact factor: 4.335

3.  Application of basic pharmacokinetic concepts to analysis of microdialysis data: illustration with imipenem muscle distribution.

Authors:  Claire Dahyot; Sandrine Marchand; Mikael Bodin; Bertrand Debeane; Olivier Mimoz; William Couet
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.

Authors:  Aldona L Baltch; William J Ritz; Lawrence H Bopp; Phyllis B Michelsen; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

5.  Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients.

Authors:  Denis Frasca; Sandrine Marchand; Franck Petitpas; Claire Dahyot-Fizelier; William Couet; Olivier Mimoz
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

6.  Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.

Authors:  Maria C Kjellsson; Laura E Via; Anne Goh; Danielle Weiner; Kang Min Low; Steven Kern; Goonaseelan Pillai; Clifton E Barry; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

Review 7.  A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.

Authors:  Tony K L Kiang; Urs O Häfeli; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

Review 8.  Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.

Authors:  Amelia N Deitchman; M Tobias Heinrichs; Vipada Khaowroongrueng; Satyawan B Jadhav; Hartmut Derendorf
Journal:  AAPS J       Date:  2016-12-09       Impact factor: 4.009

Review 9.  The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.

Authors:  Marta Ulldemolins; Jason A Roberts; Jordi Rello; David L Paterson; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

10.  Pharmacokinetic-pharmacodynamic model to evaluate intramuscular tetracycline treatment protocols to prevent antimicrobial resistance in pigs.

Authors:  Amais Ahmad; Kaare Græsbøll; Lasse Engbo Christiansen; Nils Toft; Louise Matthews; Søren Saxmose Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.